BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 23756208)

  • 1. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
    Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor-related protein 5 governs Wnt-mediated osteoarthritic cartilage destruction.
    Shin Y; Huh YH; Kim K; Kim S; Park KH; Koh JT; Chun JS; Ryu JH
    Arthritis Res Ther; 2014 Jan; 16(1):R37. PubMed ID: 24479426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury.
    Joiner DM; Less KD; Van Wieren EM; Zhang YW; Hess D; Williams BO
    Arthritis Res Ther; 2014 Mar; 16(2):R81. PubMed ID: 24670222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice.
    Bouaziz W; Sigaux J; Modrowski D; Devignes CS; Funck-Brentano T; Richette P; Ea HK; Provot S; Cohen-Solal M; Haÿ E
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5453-8. PubMed ID: 27122313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-β-catenin signaling pathway inhibition by sclerostin may protect against degradation in healthy but not osteoarthritic cartilage.
    Wu J; Ma L; Wu L; Jin Q
    Mol Med Rep; 2017 May; 15(5):2423-2432. PubMed ID: 28259981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling contributes to articular cartilage homeostasis through lubricin induction in the superficial zone.
    Xuan F; Yano F; Mori D; Chijimatsu R; Maenohara Y; Nakamoto H; Mori Y; Makii Y; Oichi T; Taketo MM; Hojo H; Ohba S; Chung UI; Tanaka S; Saito T
    Arthritis Res Ther; 2019 Nov; 21(1):247. PubMed ID: 31771658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
    Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
    Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
    Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
    Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis.
    Lodewyckx L; Luyten FP; Lories RJ
    Rheumatology (Oxford); 2012 Nov; 51(11):1973-8. PubMed ID: 22850184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis.
    van den Bosch MH; Blom AB; Kram V; Maeda A; Sikka S; Gabet Y; Kilts TM; van den Berg WB; van Lent PL; van der Kraan PM; Young MF
    Osteoarthritis Cartilage; 2017 Nov; 25(11):1900-1911. PubMed ID: 28735021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbfβ regulates Wnt/β-catenin, Hippo/Yap, and Tgfβ signaling pathways in articular cartilage homeostasis and protects from ACLT surgery-induced osteoarthritis.
    Chen W; Lu Y; Zhang Y; Wu J; McVicar A; Chen Y; Zhu S; Zhu G; Lu Y; Zhang J; McConnell M; Li YP
    Elife; 2024 May; 13():. PubMed ID: 38805545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
    Jing Z; Wei-jie Y; Yi-Feng ZG
    Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP6AP2, a regulator of LRP6/β-catenin protein trafficking, promotes Wnt/β-catenin signaling and bone formation in a cell type dependent manner.
    Xiong L; Guo HH; Pan JX; Ren X; Lee D; Chen L; Mei L; Xiong WC
    Bone Res; 2024 May; 12(1):33. PubMed ID: 38811544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
    Meo Burt P; Xiao L; Hurley MM
    Endocrinology; 2018 Jun; 159(6):2386-2396. PubMed ID: 29718273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.
    Ahn Y; Sims C; Murray MJ; Kuhlmann PK; Fuentes-Antrás J; Weatherbee SD; Krumlauf R
    Development; 2017 Aug; 144(15):2824-2836. PubMed ID: 28694256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; de Hooge P; van den Berg WB
    Osteoarthritis Cartilage; 2005 Jan; 13(1):66-73. PubMed ID: 15639639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin alleviates osteoarthritis progression via inhibiting Wnt/β-catenin signaling.
    Chen J; Liu J; Chen S; Lai R; Zheng C; Lu J; Jiang X; He F; Yang C; Li K; Xie K; Tang Y; Wang L
    Int Immunopharmacol; 2022 Nov; 112():109225. PubMed ID: 36095950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.